Total Payments
$690.30
2024 Payments
$690.30
Companies
7
Transactions
20

Payment Breakdown by Category

Food & Beverage$690.30 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $690.30 20 100.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $432.54 9 $0 (2024)
Kyowa Kirin, Inc. $88.16 4 $0 (2024)
Amgen Inc. $52.55 2 $0 (2024)
Aurinia Pharma U.S., Inc. $47.24 2 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $25.82 1 $0 (2024)
Mallinckrodt Hospital Products Inc. $25.25 1 $0 (2024)
Xeris Pharmaceuticals, Inc. $18.74 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $690.30 20 AstraZeneca Pharmaceuticals LP ($432.54)

All Payment Transactions

20 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/18/2024 Mallinckrodt Hospital Products Inc. TERLIVAZ (Drug) Food and Beverage In-kind items and services $25.25 General
Category: CRITICAL CARE
11/06/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $20.44 General
Category: LUPUS NEPHRITIS
10/30/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $32.65 General
Category: Cardiovascular and Metabolism
10/24/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $20.00 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
10/17/2024 Xeris Pharmaceuticals, Inc. GVOKE HYPOPEN (Drug) Food and Beverage In-kind items and services $18.74 General
Category: Diabetes
10/16/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $120.87 General
Category: Cardiovascular and Metabolism
09/26/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $25.82 General
Category: Cardio-renal
09/18/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $24.00 General
Category: Cardiovascular and Metabolism
08/29/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $30.88 General
Category: Cardiovascular and Metabolism
08/14/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $22.88 General
Category: Cardiovascular and Metabolism
08/07/2024 Aurinia Pharma U.S., Inc. LUPKYNIS (Drug) Food and Beverage In-kind items and services $26.80 General
Category: LUPUS NEPHRITIS
07/31/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $22.18 General
Category: Inflammation
07/25/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $23.16 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
07/03/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $28.06 General
Category: Cardiovascular and Metabolism
06/12/2024 Amgen Inc. TAVNEOS (Drug) Food and Beverage In-kind items and services $30.37 General
Category: Inflammation
06/12/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $22.77 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
05/29/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $17.47 General
Category: Cardiovascular and Metabolism
05/15/2024 Kyowa Kirin, Inc. Crysvita (Drug) Food and Beverage In-kind items and services $22.23 General
Category: fibroblast growth factor 23 (FGF23) blocking antibody.
04/24/2024 AstraZeneca Pharmaceuticals LP LOKELMA (Drug) Food and Beverage In-kind items and services $30.73 General
Category: Cardiovascular and Metabolism
04/18/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Cardiovascular and Metabolism

About Dr. Sayed Mahdi Ayat, MD

Dr. Sayed Mahdi Ayat, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Staten Island, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2018. The National Provider Identifier (NPI) number assigned to this provider is 1063909216.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sayed Mahdi Ayat, MD has received a total of $690.30 in payments from pharmaceutical and medical device companies, with $690.30 received in 2024. These payments were reported across 20 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($690.30).

Practice Information

Products in Payments

  • FARXIGA (Drug) $245.87
  • LOKELMA (Drug) $186.67
  • Crysvita (Drug) $88.16
  • TAVNEOS (Drug) $52.55
  • LUPKYNIS (Drug) $47.24
  • Kerendia (Drug) $25.82
  • TERLIVAZ (Drug) $25.25
  • GVOKE HYPOPEN (Drug) $18.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Staten Island